Dahl E, Nordal K P, Halse J, Flatmark A
Department of Surgery, The National Hospital, Oslo, Norway.
Scand J Urol Nephrol. 1992;26(3):283-8. doi: 10.3109/00365599209180884.
Using repeat bone biopsies, we studied whether 1) subtotal parathyroidectomy (PTX) enhances aluminum (Al) deposition in bone and 2) whether pretransplant PTX affects Al removal from bone after kidney transplantation. Twenty-four kidney graft recipients, 10 subjected to PTX 9-44 months prior to transplantation and 14 controls matched for dialysis duration, had bone biopsies taken at transplantation. Serum calcium and parathyroid hormone levels had decreased after PTX in all 10. At transplantation, eroded bone surface was lower in PTX-recipients, while extent of Al-stained bone surface and prevalence of symptomatic Al-related bone disease were similar in both groups (PTX: 2/10; non-PTX: 4/14). Hence, PTX did not enhance accumulation of stainable bone Al nor increase prevalence of clinical bone disease during dialysis. Fourteen (7 PTX) recipients with functioning grafts had a second biopsy 12 months after transplantation. Symptomatic Al-related bone disease was cured regardless of pretransplant PTX, and Al-stained surface had decreased in all but one (PTX) recipient.
我们通过重复进行骨活检,研究了以下两个问题:1)甲状旁腺次全切除术(PTX)是否会增加骨中铝(Al)的沉积;2)移植前进行PTX是否会影响肾移植后骨中铝的清除。24例肾移植受者,其中10例在移植前9 - 44个月接受了PTX,另外14例作为对照,根据透析时间进行匹配,所有患者在移植时均进行了骨活检。10例接受PTX的患者血清钙和甲状旁腺激素水平均有所下降。移植时,PTX受者的骨侵蚀表面较低,而两组中铝染色骨表面的范围和有症状的铝相关骨病的患病率相似(PTX组:2/10;非PTX组:4/14)。因此,PTX在透析期间既没有增加可染色骨铝的积累,也没有增加临床骨病的患病率。14例(7例PTX)移植肾功能良好的受者在移植后12个月进行了第二次活检。无论移植前是否进行PTX,有症状的铝相关骨病均得到治愈,除1例(PTX)受者外,所有受者的铝染色表面均有所减少。